prikaz prve stranice dokumenta Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split
  Download
PDF 403.16 KB
master's thesis
Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split
2022. urn:nbn:hr:171:139212
Ashraf, Hishaam
University of Split
School of Medicine

Cite this document

Ashraf, H. (2022). Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split (Master's thesis). Split: University of Split, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:171:139212

Ashraf, Hishaam. "Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split." Master's thesis, University of Split, School of Medicine, 2022. https://urn.nsk.hr/urn:nbn:hr:171:139212

Ashraf, Hishaam. "Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split." Master's thesis, University of Split, School of Medicine, 2022. https://urn.nsk.hr/urn:nbn:hr:171:139212

Ashraf, H. (2022). 'Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split', Master's thesis, University of Split, School of Medicine, accessed 27 February 2025, https://urn.nsk.hr/urn:nbn:hr:171:139212

Ashraf H. Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split [Master's thesis]. Split: University of Split, School of Medicine; 2022 [cited 2025 February 27] Available at: https://urn.nsk.hr/urn:nbn:hr:171:139212

H. Ashraf, "Characteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split", Master's thesis, University of Split, School of Medicine, Split, 2022. Available at: https://urn.nsk.hr/urn:nbn:hr:171:139212

Please login to the repository to save this object to your list.
Metadata
TitleCharacteristics of patients with preserved, mildly reduced and reduced ejection fraction heart failure treated in Split
Title (croatian)Karakteristike pacijenata s očuvanom, srednjom i smanjenom funkcijom rada srčane klijetke kod zatajenja srca liječenih u Splitu
AuthorHishaam Ashraf
MentorDuška Glavaš (mentor)
Committee memberJoško Božić (predsjednik povjerenstva)
Committee memberZrinka Jurišić (član povjerenstva)
Committee memberTina Tičinović Kurir (član povjerenstva)
GranterUniversity of Split
School of Medicine
Split
Defense date and country2022-07-08, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract
Objectives: The aims and objectives of this study were to compare the baseline characteristics of patients treated for heart failure with reduced (HFrEF), mildly-reduced (HFmrEF) and preserved (HFpEF) ejection fraction according to data obtained from the Croatian registry for patients with heart failure. Materials and Methods: This retrospective study included a total of 869 patients hospitalised with heart failure of which 322 had HFpEF, 150 had HFmrEF and 397 had HFrEF. All patient data... More was extracted from the Croatian registry for patients with heart failure and analyzed using Microsoft Excel and GraphPad Prism. Results: Of the 322 patients who were treated for HFpEF, 55% were females. The average age of patients treated with HFrEF was 68 years whereas the average age in HFmrEF and HFpEF was 72 and 73 years respectively. The most common comorbidity in patients treated with HFpEF was coronary artery disease (77%), arterial hypertension (68%), and pulmonary hypertension (55%). The most common comorbidities in patients with HFmrEF were coronary artery disease (85%), arterial hypertension (68%), and atrial fibrillation (57%). The most common comorbidities in patients with HFrEF were coronary artery disease (77%), arterial hypertension (49%), and atrial fibrillation (45%). The most commonly prescribed medications in HFpEF were diuretics (78%), ACEi (63%), and beta-blockers (54%). The most commonly prescribed medication in HFmrEF were diuretics (70%), beta-blockers (65%), and ACEi (61%). The most commonly prescribed medication in HFrEF were diuretics (82%), Betablockers (65%), and ACEi (44%). Conclusions: Patients treated for HFpEF were more likely to be women and more elderly. The most common among all heart failure groups were coronary artery disease and arterial hypertension. Regarding medical management, beta-blockers were more often prescribed to HFpEF patients whereas calcium channel blockers were more often prescribed to HFmrEF and HFpEF patients. Less
Abstract (croatian)
Ciljevi: Ciljevi i zadatci ovog istraživanja bili su usporediti osnovne karakteristike bolesnika liječenih od zatajenja srca sa smanjenom, srednjom i očuvanom funkcijom rada srčane klijetke prema podatcima dobivenim iz hrvatskog registra za pacijente sa zatajenjem srca. Materijali i metode: Ova retrospektivna studija uključivala je ukupno 869 pacijenata hospitaliziranih sa zatajenjem srca od kojih je 322 imalo HFpEF, 150 HFmrEF, a 397 HFrEF. Svi podatci o pacijentima izvađeni su iz... More hrvatskog registra za pacijente sa zatajenjem srca i analizirani s pomoću Microsoft Excela i GraphPad prizme. Rezultati: Od 322 pacijenta liječena od HFpEF-a, 55 bile su žene. Prosječna dob bolesnika liječenih od HFrEF-a bila je 68 godina, dok je prosječna dob bolesnika liječenih od HFmrEFa i HFpEF-a bila 72, odnosno 73 godine. Najčešći komorbiditet u bolesnika liječenih od HFpEF-a bila je bolest koronarnih arterija (77 %), arterijska hipertenzija (68 %) i plućna hipertenzija (55 %). Najčešći komorbiditeti u bolesnika s HFmrEF-om bili su bolest koronarnih arterija (85 %), arterijska hipertenzija (68 %) i fibrilacija atrija (57 %). Najčešći komorbiditeti kod bolesnika s HFrEF-om bili su bolest koronarnih arterija (77 %), arterijska hipertenzija (49 %) i fibrilacija atrija (45 %). Najčešće propisani lijekovi za HFpEF bili su diuretici (78 %), ACEi (63 %) i beta-blokatori (54 %). Najčešće propisani lijekovi protiv HFmrEF-a bili su diuretici (70 %), beta-blokatori (65 %) i ACEi (61 %). Najčešće propisani lijekovi za HFrEF bili su diuretici (82 %), beta-blokatori (65 %) i ACEi (44 %). Zaključak: Pacijenti liječeni od HFpEF-a uglavnom su bile starije žene. Najčešća među svim skupinama zatajenja srca bila je bolest koronarnih arterija i arterijska hipertenzija. Kad je riječ o medicinskom liječenju, beta-blokatori češće su propisivani pacijentima s HFpEF-om, dok su blokatori kalcijevih kanala češće propisivani pacijentima s HFmrEF-om i HFpEF-om. Less
Keywords
Keywords (croatian)
Languageenglish
URN:NBNurn:nbn:hr:171:139212
Study programmeTitle: Medical Studies in English
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-07-11 12:29:31
accessibility

closeAccessibilityrefresh

If you wish to permanently save changes, click on Save, if not - your settings will be reset when you restart the browser.